Skip to main content
Tagasi

ISO 11737-1:2018

Sterilization of health care products -- Microbiological methods -- Part 1: Determination of a population of microorganisms on products

Üldinfo

Kehtiv alates 12.01.2018
Direktiivid või määrused
puuduvad

Standardi ajalugu

Staatus
Kuupäev
Tüüp
Nimetus
19.05.2021
Muudatus
12.01.2018
Põhitekst
Põhitekst
ISO 11737-1:2018 specifies requirements and provides guidance on the enumeration and microbial characterization of the population of viable microorganisms on or in a health care product, component, raw material or package.
NOTE 1    The nature and extent of microbial characterization is dependent on the intended use of bioburden data.
NOTE 2    See Annex A for guidance on Clauses 1 to 9.
ISO 11737-1:2018 does not apply to the enumeration or identification of viral, prion or protozoan contaminants. This includes the removal and detection of the causative agents of spongiform encephalopathies, such as scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease.
NOTE 3    Guidance on inactivating viruses and prions can be found in ISO 22442-3, ICH Q5A(R1) and ISO 13022.
ISO 11737-1:2018 does not apply to the microbiological monitoring of the environment in which health care products are manufactured.

Nõutud väljad on tähistatud *

*
*
*
PDF
226,82 € koos KM-ga
Paber
226,82 € koos KM-ga
Standardi monitooring

Teised on ostnud veel

Muudatus

ISO 11137-1:2006/Amd 2:2018

Revision to 4.3.4 and 11.2
Uusim versioon Kehtiv alates 08.11.2018
Põhitekst

ISO 11607-1:2019

Packaging for terminally sterilized medical devices -- Part 1: Requirements for materials, sterile barrier systems and packaging systems
Uusim versioon Kehtiv alates 31.01.2019
Põhitekst

ISO 11137-1:2006

Sterilization of health care products -- Radiation -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
Uusim versioon Kehtiv alates 19.04.2006
Põhitekst

ISO 11137-3:2017

Sterilization of health care products -- Radiation -- Part 3: Guidance on dosimetric aspects of development, validation and routine control
Uusim versioon Kehtiv alates 26.06.2017